The knock-offs, it argued, are putting patient health and wellbeing at risk. The lawsuit, which Novo said it filed in Delaware, alleges that Hims products including its weight-loss injections are compounded forms of semaglutide and therefore infringe on Novos patent
White, W
Quick verdict MeAgain is the best MacroFactor alternative for GLP-1 users who want food tracking connected to shots, symptoms, weight, progress, and medication context
However, this is what I'd consider to be a calculated risk
For example, people with sensitive skin may not be able to tolerate certain procedures or topical treatments
It is common for patients to come in after travel, long workdays, or when they simply feel depleted and want to support their body more intentionally